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Abstract Synaptotagmin I- and II-deficient PC12 cells (Shoji- 
Kasai et al. 11]) were used to compare the role of this protein in 
the calcium-dependent exocytosis of secretory granules and syn- 
aptic-like microvesicles (SLMVs). While neither catecholamine 
nor protein secretion from secretory granules were altered, the 
depolarization-induced acetylcholine release from SLMVs was 
no longer calcium-dependent. We propose that within the exocy- 
totic process of SLMVs, there exist two depolarization-induced 
steps. One is calcium-dependent and no longer present in synap- 
totagmin I- and II-deficient cells. The other is induced by depolar- 
ization, does not require calcium, and suffices to trigger neuro- 
transmitter release from SLMVs in synaptotagmin I- and II- 
deficient PC12 cells. 
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I. Introduction 
Synaptotagmin is an integral membrane protein implicated 
in calcium-dependent exocytosis [24] (for a recent review see 
[5]). Two types of calcium-dependent secretory vesicles have 
been shown to contain synaptotagmin; (i) synaptic vesicles [2], 
which mediate the release of classic neurotransmitters, and 
their endocrine counterpart, the synaptic-like microvesicles 
(SLMVs) [6]; and (ii) secretory granules [7-9], from which neu- 
ropeptides are secreted. Although numerous tudies in various 
systems have provided several ines of evidence for an impor- 
tant role of synaptotagrnin i neurotransmitter release from 
synaptic vesicles [l(LI8], its involvement in secretory granule 
exocytosis is less clear [1,19,20]. 
In the present study, we have directly compared, in the very 
same cell, the role of synaptotagmin  the exocytosis of secre- 
tory granules and SLMVs. For this purpose, we have used the 
neuroendocrine c ll line PC I2, taking advantage of the previ- 
ous characterization of the contents of their secretory organ- 
elles [21] and the isolation of synaptotagmin I- and II-deficient 
clonal variants [1]. 
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2. Materials and methods 
2.1. Cell culture and labeling 
Cell culture. PC12 cells were propagated ingrowth medium (DMEM, 
10% horse serum, 5% fetal calf serum) as previously described [22], 
except hat the cells were grown on poly-L-lysine-coated dishes. 37°C 
and 10% CO2 were used in all the labeling and release conditions 
described below. Several clonal variants of PC12 cells were used: the 
synaptotagmin-containing clones 251 [23] and E8 [1] and the synapto- 
tagmin I- and II-deficient clones B3, D6 and F7 [1], kindly provided by 
Dr. M. Takahashi. 
Short-term [~SS]sulfate labeling and chase. PC12 cells (150 mm 
dishes) were incubated on a rocker for 30 rain in 5 ml of sulfate-free 
medium (sulfate-free DMEM supplemented with 1% dialysed horse 
serum and 0.5% dialysed fetal calf serum) followed by replacement of
the medium with 5 ml of sulfate-free medium containing 0.8 mCi/ml 
carrier-free [35S]sulfate (Amersham SJS. 1) and incubation for 5 min on 
a rocker. At the end of the [35S]sulfate labeling, the labeling medium was 
removed and the cells were chased for the indicated periods of time in 
15 ml of 5K/Ca-medium (127 mM NaC1, 5 mM KC1, 2.2 mM CaC12, 
0.33 mM Na2HPO4, 0.44 mM KHzPO 4, 4.2 mM NaHCO3, 5.6 mM 
glucose, and 10 mM HEPES-NaOH: pH 7.4) containing 1.6 mM 
Na2SO4. After the first 10 min of chase, the medium was discarded and 
replaced by fresh chase medium. At the end of the chase, cells and 
medium were collected and processed for the determination f SgII and 
heparan sulfate proteoglycan secretion as described [22]. 
Long-term labeling with FSS]sulfate and FH]noradrenaline. PC12 
cells grown on 150 mm dishes were incubated on a rocker for 30 min 
in 5 ml of sulfate-free medium followed by replacement of the medium 
with 15 ml of sulfate-free medium containing 67 gtCi/ml carrier-free 
[35S]sulfate and incubation for 6 h without rocking. At the end of the 
[35S]sulfate labeling, the cells were incubated for 16 h in 25 ml of chase 
medium (growth medium containing 1.6 mM Na2SO4) containing 0.5 
,uCi/ml l-[7,8-3H]noradrenaline (40 Ci/mmol; Amersham TRK.584). 
Long-term FH]choline labeling. PCI2 cells grown in 150 mm dishes 
were incubated for 16 h in 15 ml of growth medium containing 2.66 
~uCi/ml of [methyl3H]choline chloride (75 85 Ci/mmol; Amersham 
TRK.593). 
2.2. Depolarization-induced SglI, noradrenaline and acetylcholine 
release 
Cell stimulation. PCI2 cells were long-term labeled with [35S]sulfate 
plus [3H]noradrenaline, orwith [3H]choline. At the end of the labeling, 
the cells were chased 3 times for 10 min with 5 ml of either 5K/Ca- 
medium (for conditions 1and 2, see Figs. 2 and 4) or 5K/Mg-medium 
(5K/Ca-medium in which 2.2 mM CaC12 was replaced by 10 mM 
MgC12) (for conditions 3 and 4). After the chase, the medium was 
replaced by 5 ml of 5K/Ca-medium (condition 1), 55K/Ca-medium 
(5K/Ca-medium in which 127 mM NaC1 and 5 mM KC1 were replaced 
by 77 mM NaCI and 55 mM KCI) (condition 2), 5K/Mg-medium 
(condition 3), or 55K/Mg-medium (5K/Mg-medium in which 127 mM 
NaC1 and 5 mM KCI were replaced by 77 mM NaCI and 55 mM KCI) 
(condition 4), and the cells were incubated for 15 min for SgII and 
noradrenaline r lease or 5 min for acetylcholine r lease. At the end of 
the stimulation, the dishes were placed on ice, the release medium was 
removed, and the cells were scraped off the dish in 10 ml of ice-cold 
phosphate-buffered saline and pelleted by centrifugation at800 × g,v for 
10 min. The pellet was resuspended in 1 ml of SDS-PAGE-sample 
buffer, and analyzed for [35S]sulfate-labeled SgII by SDS-PAGE (see 
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below) and for [3H]noradrenaline or total [3H]choline-labeled material 
by liquid scintillation counting. The release medium was centrifuged for 
7 rain at 1,800 rpm in a Heraeus minifuge. The supernatant was centri- 
fuged for 30 min at 35K rpm in a Beckman Ti70.1 rotor. Aliquots of 
the high-speed supernatant were analyzed for [3H]noradrenaline by 
liquid scintillation counting and for [3H]choline/acetyl[3H]choline by 
liquid scintillation counting and agarose gel electrophoresis ( ee below). 
Other aliquots (1 ml) of the high-speed supernatant were acetone- 
precipitated and analyzed for [35S]sulfate-labeled SglI by SDS-PAGE 
and fluorography. 
Agarose gel eleetrophoresis. To separate acetyl[~H]choline and 
[3H]choline from other [3H]choline-labeled molecules, we used agarose 
gel electrophoresis at pH 3.5 instead of the previously described two- 
dimensional cellulose thin-layer electrophoresis fir t at pH 1.9 and then 
at pH 3.5 [21]. The high-speed supernatant prepared from the release 
medium was diluted (l:1, v/v) with electrophoresis buffer (5% (v/v) 
acetic acid, 0.5% (v/v) pyridine, pH 3.5) and applied onto an agarose 
gel (1% in electrophoresis buffer). Electrophoresis was carried out at 
100 V for 1 h. [-~H]Acetylcholine (NEN, NET- 113) was used as a stand- 
ard. The agarose gel was sectioned into pieces (0.5-cm in length), the 
gel pieces were melted in a microwave oven, mixed with 10 ml Ecoscint 
H (National Diagnostics) and 3H-radioactivity was determined by liq- 
uid scintilation counting. 
2.3. Subcellular f actionation and immunoblotting 
Post-nuclear supernatants were prepared from unlabeled PCI 2 cells, 
subjected to preparative sequential differential centrifugation to yield 
P40 pellets, and the P40 pellets analyzed by equilibrium sucrose gradi- 
ent centrifugation, using previously described procedures ( ee [21] and 
refs. therein). Fractions were analysed by immunoblotting as previously 
described [24] except that blocking of the nitrocellulose heets was in 
PBS containing 10% (w/v) low fat milk powder and 0.1% (w/v) Tween- 
20 for 2 h at room temperature. For SgII, the rabbit anti hSgII~ 20 
peptide antiserum [25], a kind gift of Dr. H.-H. Gerdes, was used at a 
dilution of 1:200, followed by [~251]protein A (0.12 ,uCi/ml final; NEN). 
For synaptophysin, the mouse monoclonal antibody SY38 [26] 
(Boehringer-Mannheim) was used at 0.2 ,ug/ml final concentration. For 
synaptotagmin, the mouse monoclonal ntibody 41.1 [4], a kind gift of 
Dr. R. Jahn, Yale University, New Haven, was used at 1 ~tg/ml final 
concentration. Both monoclonal ntibodies were detected by incuba- 
tion with 1 ,ug/ml of rabbit anti-mouse IgG and [~25I]protein A (0.12 
/~Ci/ml final; N EN). Immunoreactivity was quantitated by densitomet- 
ric scanning of the autoradiogram derived from the immunoblots. For 
qualitative analysis (Fig. IA), blots were incubated with the above 
primary antibodies followed by horseradish peroxidase-coupled s c- 
ondary antibodies and detection using the ECL system (Amersham). 
3. Results and discussion 
3.1. Synaptotagmin I- and lI-deficient PC12 cells" contain both 
secretory granules and SLMVs 
The synaptotagmin 1- and II-deficient PC12 cell clones B3, 
D6 and F7 [1] (Fig. 1A, top) were first analyzed for the presence 
of secretogranin II (SgII) and synaptophysin, which are mark- 
ers for secretory granules [27] and SLMVs [28], respectively. All 
three clones were found to express normal evels of these two 
marker proteins when compared with two synaptotagmin-con- 
taining control PC12 cell clones, i.e. E8 [1] and 251 [23] (Fig. 
1A, middle and bottom). Because in all the experiments de- 
scribed below similar results were obtained for the control 
clones 251 and E8 and the synaptotagmin I- and H-deficient 
clones B3, D6 and F7, respectively, we have illustrated here 
only results for clones 251 and B3. 
Equilibrium sucrose gradient centrifugation f a subcellular 
fraction enriched in small vesicles (P40) [21] revealed that in the 
synaptotagmin I- and II-deficient clone B3, as in the control 
clone 251, SglI peaked in the denser fractions of the gradient 
in the position characteristic ofmature secretory granules (Fig. 
l B,E), whereas ynaptophysin was found in the lighter fractions 
in a distribution characteristic of SLMVs (fractions No. 14-15) 
and early endosomes (fractions No. 10-12) (Fig. 1C,F). Synap- 
totagmin was undetectable in the clone B3 (data not shown), 
but was associated with both SLMVs and secretory granules 
in the control PC12 cell clone 251 (Fig. 1D), as expected from 
previous reports [6-9]. We conclude that the synaptotagmin I- 
and II-deficient PC12 cells contain secretory granules and 
SLMVs which are indistinguishable from the corresponding 
vesicles of control cells upon subcellular f actionation. These 
observations imply that synaptotagmin I and II are not essen- 
tial for the formation of secretory granules and SLMVs and 
allowed us to analyze the exocytosis of these neurosecretory 
vesicles in synaptotagmin I- and II-deficient PC12 cells. 
3.2. Depolarization-induced secretion of catecholamines and 
SgH is normal in synaptotagmin I- and II-deficient PC12 
cells 
In PC12 cells, catecholamines are stored in secretory gran- 
ules, but not in SLMVs [21]. Depolarization-induced s cretion 
of catecholamines from PC12 cells therefore reflects their re- 
lease from secretory granules, not SLMVs, and the ability of 
synaptotagmin I- and II-deficient PC I2 cells to perform this 
release [1] implies that synaptotagmin I and II are not essential 
for this process. In contrast, microinjection of synaptotagmin 
antibodies and soluble synaptotagmin I fragments into PC I2 
cells was found to result in an inhibition of secretory granule 
exocytosis, as measured by the cell surface exposure of the 
membrane-anchored form of dopamine J~-hydroxylase [19]. 
One possible xplanation to reconcile these apparently con- 
tradictory observations with each other is based on the exis- 
tence of a fusion pore as an intermediate step in vesicle fusion 
[29 31]. It has been postulated that molecules uch as classic 
neurotransmitters, biogenic amines and nucleotides are re- 
leased from vesicles through the fusion pore [30,32,33]. Given 
its size, the release of such small molecules through the fusion 
pore would presumably not be accompanied by the release of 
larger soluble constituents of the vesicle such as secretory pro- 
teins, and the fusion pore would probably not allow lumenal 
domains of vesicle membrane proteins to be accessible to ex- 
tracellular probes uch as antibodies. Thus, if one assumed that 
synaptotagmin acted after the formation and opening of the 
fusion pore, its absence, or functional blockade, would still 
allow the fusion pore to open but would prevent the exocytotic 
process from proceeding beyond this step. Catecholamines 
would be released through the opened fusion pore (possi- 
bly explaining the data of Shoji-Kasai et al. [1]) which, how- 
ever, would not allow dopamine fl-hydroxylase to be detected 
by an extracellular ntibody (perhaps explaining the results of 
Elferink et al. [19]). 
To investigate his possibility, we compared the secretion of 
catecholamines from secretory granules with that of SgII, a 68 
kDa secretory protein [34] of the secretory granule matrix [27] 
which should be too large to be released through a fusion pore 
with the width of a gap junction channel [30,32]. As shown in 
Fig. 2, depolarization f the synaptotagmin I- and II-deficient 
PC12 cells in the presence of extracellular Ca 2+ (Fig. 2, condi- 
tion 2) resulted in the release not only of catecholamines (dark 
columns) but also of SglI (light columns), which was indistin- 
guishable from that observed with control PC 12 cells. For both 
compounds, this evoked release was strictly calcium-dependent 
(compare conditions 2 and 4). Thus, the observations reported 
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by Shoji-Kasai et al. [1] cannot be reconciled with those of 
Elferink et al. [ 19] by assuming an 'arrested' fusion pore caused 
by synaptotagrnin I and II deficiency. Rather, our data indicate 
that synaptotagmin I and II are not essential for regulated 
exocytosis of secretory granules in PC 12 cells, perhaps because 
related proteins uch as synaptotagmin III [35], synaptotagmin 
1V [36] and rabphilin [37] compensate for synaptotagmin I and 
II deficiency in this process. Hence, with respect o regulated 
exocytosis of secretory granules, the only known phenotype of 
synaptotagmin I and II deficiency is the one recently reported 
by Shoji-Kasai et al. [38], i.e. the loss of the ~-latrotoxin- 
induced calcium-independent catecholamine r lease [39] that is 
thought to be mediated via the direct interaction of the c~- 
latrotoxin receptor [40,41], a plasma membrane protein of the 
neurexin family [42], with synaptotagmin. 
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3.3. Synaptotagmin I and H deficiency does not result in an 
increased basal secretion from secretory granules 
Synaptotagmin has been proposed to be an inhibitor of ex- 
ocytosis unless cytoplasmic calcium is elevated [43]. If so, one 
might expect an increased basal exocytosis of secretory gran- 
ules in synaptotagmin I- and II-deficient PC12 cells. To investi- 
gate this possibility, we studied the secretion of SglI from newly 
formed secretory granules by pulse-labeling these cells with 
[35S]sulfate for 5 min and chasing for up to 100 min, without 
any stimulation (compare [22] and [44]). As shown in Fig. 3, no 
significant release of SglI was detectable, while that of the 
heparan sulfate proteoglycan, a marker for the constitutive 
pathway of protein secretion in PC 12 cells [22,44], was virtually 
complete by 100 min (Fig. 3B), as has been previously observed 
for synaptotagmin-containing PC 12 cells [22,44]. Thus, the lack 
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Fig. 1. Synaptotagmin I- and I l-deficient PC12 cells contain both secretory granules and SLMVs. (A) Cell homogenates (15 ~g protein) of the PC 12 
cell control clones 251 and E8 and of the synaptotagmin I- and II-deficient clones B3, D6, and F7 were analysed by immunoblotting forthe presence 
of synaptotagmin, SglI and synaptophysin. (B F) Membrane pellets enriched in small vesicles (P40) were prepared from the PC12 cell control clone 
251 (D-F) and the synaptotagmin I- and II-deficient clone B3 (B and C), and subjected to equilibrium sucrose gradient centrifugation. The gradient 
fractions (fraction 1 = bottom) were analyzed by immunoblotting forthe presence of synaptotagrnin (D), the secretory granule marker SglI (B and 
E) and the SLMV marker synaptophysin (C and F). For each marker, values are expressed as percentage oftotal recovered inthe sum of the gradient 
fractions. 
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Fig. 2. Depolarization-induced s cretion of noradrenaline and Sgll 
from secretory granules of synaptotagmin I- and II-deficient PC12 cells 
is indistiguishable from that of control PCI2 cells. After long-term 
labeling with [3H]noradrenaline and [35S]sulfate, control (clone 251) and 
synaptotagmin I- and II-deficient (clone B3) PC12 cells were incubated 
in various conditions and analyzed for the secretion of [3H]noradrenal- 
ine (dark columns) and [35S]SgII (light columns) induced by 55 mM 
KC1. Condition 1 : 5K/Ca-medium; condition 2: 55K/Ca-medium; con- 
dition 3: 5K/Mg-medium; condition 4: 55K/Mg-medium. For each 
marker secreted, individual values were calculated as percentage of 
total recovered in cells plus medium. The means of four independent 
experiments are shown. For [3H]noradrenaline, the mean of the unstim- 
ulated control cells (clone 251, condition 1) was arbitrarily set to 100 
and the other means expressed relative to this. Bars indicate S.E.; for 
some columns, these were too small to be depicted. 
of synaptotagmin I and II does not result in an increased basal 
secretion from secretory granules. 
3.4. Depolarization-induced acetyleholine r lease from SLMVs 
of synaptotagmin I- and II-deficient PC12 cells is no longer 
calcium-dependent 
To investigate a possible effect of synaptotagmin I and II 
deficiency on the exocytosis of SLMVs, we took advantage of 
our previous observation that after [3H]choline-labeling of
PC 12 cells, these organelles (but not secretory granules) contain 
biosynthetic acetyl[3H]choline [21]. To prevent ace- 
tyl[3H]choline which is present in early endosomes [21] and 
which may be secreted from these organelles via constitutive 
membrane r cycling to the plasma membrane [45] from contrib- 
uting to the acetyl[3H]choline r lease, we reduced the en- 
dosomal acetyl[3H]choline pool by a chase prior to stimulation. 
As shown in Fig. 4A, the subsequent basal acetyl[3H]choline 
release observed in the absence of stimulation (condition 1) was 
virtually identical for the control and the synaptotagmin I- and 
II-deficient PC12 cell clone. Upon depolarization, both the 
control and the synaptotagmin I- and II-deficient PCl2 cell 
clone exhibited a similar increase in acetyl[3H]choline r lease 
(condition 2). However, whereas in the control PC12 cell clone 
the depolarization-induced acetyl[3H]choline release was 
strictly calcium-dependent, in the synaptotagmin I- and lI- 
deficient clone this release occurred also in the absence of 
extracellular calcium (Fig. 4A, compare conditions 2 and 4). 
To investigate whether the 3H-labeled material released from 
[3H]choline-labeled cells was indeed acetyl[3H]choline, we ana- 
lyzed the medium of the synaptotagmin I- and II-deficient clone 
B3 in conditions 2 and 4 by agarose gel electrophoresis at pH 
3.5 (Fig. 4B). We have previously shown that after [3H]choline- 
labeling of cells, the only radioactive compounds migrating 
towards the cathode at pH 3.5 are acetyl[3H]choline and 
[3H]choline itself, with [3H]choline running slightly ahead of 
acetyl[3H]choline [21]. As shown in Fig. 4B, in both condition 
2 and 4 the vast majority of the 3H-radioactivity was recovered 
in a peak that comprised both the position of the ace- 
tyl[3H]choline standard and that of free [3H]choline, and hence 
most likely corresponded to a mixture of [3H]choline plus 
acetyl[3H]choline. The presence of [3H]choline in the release 
medium can be explained by (i) substantial mounts of choline, 
in addition to acetylcholine, being present in SLMVs [21] and 
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Fig. 3. Synaptotagmin I- and II-deficient PCI2 cells do not exhibit an 
increased basal release of SgII. Synaptotagmin I- and II-deficient PC 12 
cells (clone B3) were short-term labeled with [35S]sulfate and then 
chased for the indicated time periods. Aliquots of the various chase 
media (one fifth) and of the cells at the end of the chase (one tenth) were 
analyzed by SDS-PAGE followed by fluorography (A). The heparan 
sulfate proteoglycan (PG), a marker for the constitutive pathway of 
protein secretion, was quantified and is expressed as percent of that 
found in the medium after a 100 rain chase (B). Note that over a chase 
period which results in the secretion of the bulk of the constitutively 
secreted heparan sulfate proteoglycan, SgIl is stored in the cells and not 
detectable in the medium (arrowheads). 
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(ii) the extracellular degradation of released acetyl[3H]choline 
by the PC12 cell acetylcholine esterase [46]. 
How can we explain that, irrespective of the absence or 
presence of extracellular calcium, equal amounts of 
[3H]choline/acetyl[3H]choline ar released upon high K+-in -
duced depolarization fsynaptotagmin I- and II-deficient PC I2 
cells? One possibility is that in these cells, the release was not 
due to exocytosis of SLMVs but to a reversal of the sodium- 
dependent choline transport across the plasma membrane [47- 
49]. The latter may have been caused by the reduction in the 
sodium concentration f the high K ÷ release medium which was 
done to keep its osmolarity constant. This explanation implies 
that (i) the 3H-labeled material released from the synaptotag- 
rain I- and II-deficient cells was mostly [3H]choline (with some 
of it trailing in the electrophoresis); (ii) the reversal of sodium- 
dependent choline transport across the plasma membrane in 
the high K + medium occurred only in the synaptotagmin I- and 
II-deficient, but not the control, PC12 cells (as there was no 
increase in release in condition 4with clone 251); and (iii) most 
importantly, the synaptotagmin I- and II-deficient PC l2 cells, 
in contrast o control PC12 cells, did not exhibit [3H]choline/ 
acetyl[3H]choline r lease from SLMVs in the presence of ex- 
tracellular calcium (as the release in conditions 2 and 4 was 
equal for clone B3). In other words, the high K+-induced release 
of [3H]choline/acetyl[3H]choline from control PC12 cells re- 
flected exocytosis of SLMVs whereas that from synaptotagmin 
I- and II-deficient cells was due to transport of cytosolic 
[3H]choline across the plasma membrane. In this scenario, our 
results would suggest an essential role of synaptotagmin I i the 
exocytosis of SLMVs induced by depolarization. 
Alternatively, if we interpret the high K÷-induced release of 
[3H]choline/acetyl[3H]choline from the synaptotagmin I- and 
II-deficient PC12 cells in the context of SLMV exocytosis, we 
are left with two possibilities. First, the release in the absence 
of extracellular calcium was due to a depolarization-induced 
mobilization of calcium from intracellular stores. We find this 
unlikely because this should also have resulted in the exocytosis 
of secretory granules, which are known to require lesser in- 
creases in cytosolic alcium than synaptic vesicles [50]. How- 
ever, no depolarization-induced noradrenaline and SgII release 
was detected in this condition (compare Fig. 2, condition 4). 
Furthermore, asthere was no depolarization-induced release of 
[3H]choline/acetyl[3H]choline from control PC12 cells (Fig. 4A 
left, condition 4), one would have to assume that calcium mo- 
bilization from intracellular stores occurred only in the synap- 
totagmin I- and II-deficient cells. 
Second, in the synaptotagmin I- and II-deficient PC12 cells, 
the depolarization-induced exocytosis of SLMVs was no longer 
calcium-dependent. This conclusion isdistinct from the various 
interpretations of data obtained with neurons of synaptotag- 
min-deficient animals [11-15,17,18] including mice [16,51]. The 
fusion of synaptic vesicles with the presynaptic membrane in
neurons differs in several aspects from the exocytosis of 
SLMVs in neuroendocrine cells, and hence even for mammal- 
ian cells the phenotype of synaptotagmin deficiency may well 
depend on the system studied. With respect to SLMV exocyto- 
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control cells (clone 251, condition 1) being arbitrarily set to 100 and the other means expressed relative to this. Bars indicate S.E.; for some columns, 
these were too small to be depicted. Open diamonds indicate values tatistically different from those of condition 1, asterisks those different from 
condition 3, as calculated using the paired Student's t-test (o P < 0.05; ~>~ P -< 0.005; *~', P -< 0.005). (B) Agarose gel electrophoresis (origin on the 
left, cathode on the right) of the release media from condition 2and 4 of clone B3 (compare panel A). Values are expressed aspercentage of the 
total 3H-radioactivity recovered in the gel. The bar indicates the position of the acetyl[3H]choline standard. 
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sis, our data would imply that the stimulation-induced event 
within the fusion process of SLMVs consists of at least two 
distinct steps. One is calcium-dependent a d no longer present 
in synaptotagmin I- and II-deficient cells. Given the properties 
of synaptotagmin [3,4], it is appealing to relate the lack of the 
calcium-dependent step in these cells to the absence of synapto- 
tagmin I and II, although it cannot be excluded that synapto- 
tagmin deficiency is not the only difference between these cells 
and control PC12 cells. The other step is induced by depolari- 
zation, does not require calcium, and suffices to trigger SLMV 
(but not secretory granule) exocytosis in synaptotagmin I- and 
lI-deficient PC12 cells. 
The role of depolarization i neurotransmitter r lease has 
been controversial [52-55]. According to the calcium hypothe- 
sis (see [52] and refs. therein), membrane depolarization is nec- 
essary only for opening calcium channels. The calcium-voltage 
hypothesis (see ref. 54 and refs. therein), on the other hand, 
postulates that depolarization induces aconformational change 
in a membrane protein, rendering it sensitive to calcium. Upon 
calcium entry into the synapse (which is also induced by depo- 
larization), the binding of calcium to the thus sensitized form 
of this protein triggers neurotransmitter r lease. The present 
results upport he calcium-voltage hypothesis [54], if modified 
such that distinct, but interacting, proteins are the targets for 
calcium and depolarization. Considering current models of the 
molecular components of the docking/fusion machinery and 
their interactions with each other [56-58], synaptotagmin a d 
related proteins, as previously proposed (for reviews ee [5,43]), 
would be the calcium targets mediating the calcium-dependence 
of neurotransmitter r lease. However, the depolarization-in- 
duced, but calcium-independent acetylcholine release from 
SLMVs occurring in synaptotagmin I- and II-deficient PC12 
cells leads us to propose that there exists an additional regu- 
lated step in the fusion process, which is mediated by proteins 
other than synaptotagmin I and II that are sensitive to mem- 
brane depolarization. Perhaps ome of the plasma membrane 
proteins implicated in synaptic vesicle (and, by analogy, 
SLMV) exocytosis uch as syntaxin [59-61], SNAP-25 [60,62] 
and the neurexins [4042] need to undergo a conformational 
change in the course of the fusion process, and depolarization 
induces this conformational change. After all, depolarization- 
induced conformational changes are well established for mem- 
brane proteins uch as voltage-gated ion channels. 
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